Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 36, Issue 6, 1997, Pages 835-843

  Campbell, Magda ^b   Armenteros, Jorge L ^c   Malone, Richard P ^c   Adams, Phillip B ^c   Eisenberg, Zena W ^c   Overall, John E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

Autism; Children; Neuroleptic related dyskinesias; Prospective study

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; PLACEBO;

ARTICLE; AUTISM; CHILD; DRUG EFFECT; DRUG SCREENING; DYSKINESIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 0030927811     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199706000-00022     Document Type: Article

References (39)

1. American Psychiatric Association (1980), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III). Washington, DC: American Psychiatric Association
2. American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-Revised (DSM-III-R). Washington, DC: American Psychiatric Association
3. Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J (1989), The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord 19:227-239
4. Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH (1984), Haloperidol in infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry 141:1195-1202
5. Armenteros JL, Adams PB, Campbell M, Eisenberg ZW ( 1995), Haloperidol related dyskinesias and pre- and perinatal complications in autistic children. Psychopharmacol Bull 31:363-369
6. Campbell M (1985a), Protocol for rating drug-related AIMS, stereotypies, and CPRS assessments. Psychopharmacol Bull 21:1081
7. Campbell M (1985b), Timed Stereotypies Rating Scale. Psychopharmacol Bull 21:1082
8. Campbell M, Adams P, Perry R, Spencer EK, Overall JE (1988), Tardive and withdrawal dyskinesia in autistic children: a prospective study. Psychopharmacol Bull 24:251-255
9. Campbell M, Anderson LT, Meier M et al. (1978), A comparison of haloperidol and behavior therapy and their interaction in autistic children. J Am Acad Child Psychiatry 17:640-655
10. Campbell M, Armenteros JL, Eisenberg ZW (in press), Neuroleptic-related dyskinesias in children and adolescents. In: New Research on the Course and Treatment of Tardive Dyskinesia, Szymanski S, ed. Washington, DC: American Psychiatric Press
11. Campbell M, Grega DM, Green WH, Bennett WG (1983), Neuroleptic-induced dyskinesias in children. Clin Neuropharmacol 6:207-222
12. Campbell M, Locascio JJ, Choroco MC et al. (1990), Stereotypies and tardive dyskinesia: abnormal movements in autistic children. Psychopharmacol Bull 26:260-266
13. Cohen IL, Campbell M, Posner D, Small AM, Triebel D, Anderson LT (1980), Behavioral effects of haloperidol in young autistic children: an objective analysis using a within-subjects reversal design. J Am Acad Child Psychiatry 19:665-677
14. Engelhardt DM, Polizos P (1978), Adverse effects of pharmacotherapy in childhood psychosis. In: Psychopharmacology: A Generation of Progress, Lipton MA, DiMascio A, Killam KF, eds. New York: Raven Press, pp 1463-1469
15. Gardos G, Cole JO (1980), Problems in the assessment of tardive dyskinesia. In: Tardive Dyskinesia: Research and Treatment. Fann WE, Smith RC, Davis JM, Domino EF, eds. Jamaica, NY: Spectrum Publications, pp 201-214
16. Gilbert PL, Harris MJ, McAdams LA, Jeste DV (1995), Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry 52:173-188
17. Granacher RP (1981), Differential diagnosis of tardive dyskinesia: an overview. Am J Psychiatry 138:1288-1297
18. Gualtieri CT, Quade D, Hicks RE, Quade D (1984), Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. Am J Psychiatry 141:20-23
19. Gualtieri CT, Schroeder SR, Hicks RE, Quade D (1986), Tardive dyskinesia in young mentally retarded individuals. Arch Gen Psychiatry 43:335-340
20. Kane JM (1992), Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Association
21. Kane JM (1995), Tardive dyskinesia: epidemiological and clinical presentation. In: Psychopharmacolagy: The Fourth Generation of Progress, Bloom FE, Kupfer DJ, eds. New York: Raven Press, pp 1485-1496
22. Kane JM, Woerner M, Lieberman J (1988), Tardive dyskinesia: prevalence, incidence and risk factors. J Clin Psychopharmacol 8:52S-56S
23. Khot V, Wyatt RJ (1991), Not all that moves is tardive dyskinesia. Am J Psychiatry 148:661-666
24. Meiselas K, Spencer EK, Oberfield R, Peselow ED, Angrist B, Campbell M (1989), Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children. J Clin Psychopharmacol 9:207-209
25. Overall JE (1980), Continuity correction for Fisher's exact probability test. J Educ Stat 5:177-190
26. Overall JE, Starbuck RR (1983), F-test alternatives to Fisher's exact test and to the chi-square test of homogeneity in 2 ' 2 tables. J Educ Stat 8:59-73
27. Perry R, Campbell M, Adams P et al. (1989a), Long-term efficacy of haloperidol in autistic children: continuous vs discontinuous drug administration. J Am Acad Child Adolesc Psychiatry 28:87-92
28. Perry R, Nobler MS, Campbell M (1989b), Case report: Tourette-like symptoms associated with chronic neuroleptic therapy in an autistic child. J Am Acad Child Adolesc Psychiatry 28:93-96
29. Psychopharmacol Bull (1985), Special Feature: Rating scales and assessment instruments for use in pediatric psychopharmacology research. 21(4)
30. Richardson MA, Haugland G, Craig TJ (1991), Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Am J Psychiatry 148:1322-1328
31. Sallee FR, Stiller RL, Perel JM, Everett G (1989), Pemoline-induced abnormal involuntary movements. J Clin Psychopharmacol 9:125-129
32. Schooler NR, Kane JM (1982), Research diagnoses for tardive dyskinesia (letter). Arch Gen Psychiatry 39:486-487
33. Shay J, Sanchez LE, Cueva JE, Armenteros JL, Overall JE, Campbell M (1993), Neuroleptic-related dyskinesias and stereotypies in autistic children: videotaped ratings. Psychopharmacol Bull 29:359-363
34. Silva RR, Malone RP, Anderson LT, Shay J, Campbell M (1993), Haloperidol withdrawal and weight changes in autistic children. Psychopharmacol Bull 29:287-291
35. Simpson GM, Lee JH, Zoubok B, Gardos G (1979), A rating scale for tardive dyskinesia. Psychopharmacology 64:171-179
36. Tsai LY, Stewart MA, August G (1981), Implication of sex differences in the familial transmission of infantile autism. J Autism Dev Disord 11:165-173
37. Weiss B, Santelli S (1978), Dyskinesias evoked in monkeys by weekly administration of haloperidol. Science 200(May):799-801
38. Yassa R, Jeste DV (1992), Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18:701-715
39. Zax M, Sameroff AJ, Babigian HM (1977), Birth outcomes in the offsprings of mentally disordered women. Am J Orthopsychiatry 47:218-230